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Case Report
Extrinsic obstruction of the left main coronary artery due to pulmonary artery 
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A B S T R A C T
This report describes a patient with pulmonary hypertension secondary to schistosomiasis, who sought 
emergency care due to chest pain at rest. The clinical presentation and other information related to the 
case raised the suspicion of acute coronary failure, and a severe obstruction was identified in the left 
main coronary artery. The case report aimed to highlight the need for a differential diagnosis of chest 
pain complaints in these patients, and emphasizes the choice of percutaneous coronary intervention as an 
effective and safe treatment in this scenario.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Obstrução extrínseca do tronco da coronária esquerda causada por dilatação da 
artéria pulmonar associada à esquistossomíase 
R E S U M O
Relatamos o caso de um paciente portador de hipertensão pulmonar de origem esquistossomótica, que 
procurou pronto atendimento por apresentar quadro de dor torácica em repouso. A apresentação clínica 
e os demais dados referentes ao caso levantaram a suspeita de insuficiência coronariana aguda, e foi 
diagnosticada uma obstrução grave do tronco da coronária esquerda. O relato do caso teve por objetivo 
destacar a necessidade do diagnóstico diferencial da queixa de dor torácica nestes pacientes e ressaltar a 
opção da intervenção coronariana percutânea como tratamento eficaz e seguro neste cenário.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Significant obstructions in the left main coronary artery are fou-
nd in 5 to 7% of patients undergoing coronary angiography.1 Atheros-
clerotic involvement is the most frequent cause, but other causes can 
occur, such as extrinsic obstruction due to pulmonary artery dila-
tion secondary to pulmonary hypertension. 
Schistosomiasis is the third leading endemic parasitic disease in 
the world, and approximately 5.0% of infected patients also have 
pulmonary artery hypertension.2 Therefore, one of the main causes 
of pulmonary hypertension is secondary to schistosomiasis. Chest 
pain is one of the most common complaints in these patients, usu-
ally considered secondary to pulmonary hypertension.
The following case report draws attention to another possible 
cause of chest pain in these patients and emphasizes the important 
role of percutaneous coronary intervention in their treatment. 
Case report
EAB, a 66-year-old male patient, was diagnosed with schistosomia-
sis at 10 years of age. At 38, he was diagnosed with pulmonary hyper-
tension after transitory episodes of dyspnea. He remained 
asymptomatic until 53 years of age, when he started to have new episo-
des of intense dyspnea associated with atrial fibrillation. There was 
spontaneous reversion to sinus rhythm and the patient continued to 
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Figure 1. Coronary angiography to the left (right anterior oblique caudal projection) showing subocclusive obstruction in the left main coronary artery (LMCA). Coronary compu-
ted tomography angiography on the right. Note the significant main pulmonary artery dilation, causing extrinsic obstruction of the LMCA. 
receive warfarin, and he was followed-up by a pneumologist. At the 
time, pulmonary scintigraphy was negative for thromboembolism, and 
spirometry was normal. He was submitted to right heart catheteriza-
tion during the same period, which disclosed pulmonary artery systolic 
pressure of 107 mmHg (systolic pressure of 175 mmHg) with no respon-
se at the vasodilator test.  Routine echocardiograms showed right ven-
tricular dilation and systolic dysfunction, dilation of the pulmonary 
artery and main branches, and pulmonary hypertension. Annual asses-
sments of functional capacity with the 6-minute walk test showed 
values between 450 and 500 m for walked distance (reference values 
for age: 550 to 600 m). 
In 2011, at age 62, his dyspnea worsened, this time associated 
with atypical chest pain. Treatment was started with sildenafil, with 
significant improvement to functional class II of the New York Heart 
Association (NYHA). In July 2014, he developed an episode of acute 
chest pain at rest and sought emergency care. An electrocardiogram 
showed right bundle branch block, ST-segment depression, and nega-
tive T wave from V1 to V5 (alterations that had been previously pre-
sent), with sequential troponin I values of 34.7 pg/mL, 44.8 pg/mL, 
and 46.2 pg/mL (RV < 34.2 pg/mL). The patient was referred to this 
service with a diagnosis of acute coronary syndrome. Coronary an-
giography disclosed a severe, subocclusive lesion in the left main 
coronary artery, without other significant obstructions, and left 
ventriculography showed preserved systolic function (Fig. 1). Consi-
dering the previous history of significant pulmonary artery dilation 
and few angiographic signs of coronary atherosclerosis, it was deci-
ded to perform a coronary computed tomography angiography, whi-
ch showed an 80.4 -mm main pulmonar y ar ter y di lat ion 
(RV < 26 mm) causing extrinsic compression of the left main coro-
nary artery (Fig. 2). The case was discussed with the pneumologist 
and the cardiovascular surgeon. Considering the high operative risk, 
it was decided to perform a percutaneous coronary intervention. A 
4.0 × 28 mm PROMUS ElementTM drug-eluting stent (Boston Scienti-
fic – Natick, USA) was implanted in the left main coronary artery. An 
intravascular ultrasound was performed after implantation, which 
showed stent malapposition; the issue was resolved after stent dila-
tion with a 4.5 × 15 mm balloon catheter (Fig. 3). Hospital discharge 
occurred 2 days after the procedure. 
The patient had no recurrence of chest pain and the dyspnea im-
proved to functional class I (NYHA). He is currently asymptomatic 
and receives metoprolol, furosemide, simvastatin, clopidogrel, war-
farin, and sildenafil. The patient received acetylsalicylic acid for 30 
days after the procedure. Imaging follow-up was carried out with 
coronary computed tomography angiography performed 8 months 
after the procedure (Fig. 4), which showed the well-positioned stent 
with preserved lumen, with no signs of deformation or restenosis. 
Discussion
Pulmonary hypertension is triggered by the remodeling of the 
intimal and medial layers of the pulmonary vascular bed, with con-
sequent increase in vascular resistance, increased pulmonary artery 
diameter, right ventricular enlargement, and dysfunction, which can 
cause heart failure (cor pulmonale) and death.2 The most common 
causes of pulmonary hypertension are primary pulmonary hyper-
tension, congenital heart disease, chronic thromboembolic disease, 
and advanced pulmonary parenchymal disease. Causes of extrinsic 
compression of the main pulmonary artery are thoracic outlet syn-
drome, syphilis, metastatic carcinoma and bronchogenic cyst.3 
However, in countries where schistosomiasis is endemic, due to its 
high prevalence, this parasitic disease is one of the main causes of 
pulmonary hypertension. 
Pulmonary artery dilation can cause extrinsic compression of 
the left main coronary artery, resulting in significant lumen reduc-
tion. The accurate incidence of this condition is not known, and it 
can occur in 5 to 44% of patients with pulmonary hypertension.3 Its 
development depends on a chronic increase in the pulmonary ar-
tery diameter, usually associated with severe pulmonary hyper-
tension. Compression of the artery becomes probable when the 
pulmonary artery diameter is > 55 mm, or when the ratio between 
the latter and the aortic root diameter is at least 1.98.3 
The most common clinical presentation is the occurrence of angi-
nal chest pain, with or without dyspnea. However, syncope, severe 
arrhythmias, myocardial infarction, or ventricular dysfunction may 
also be present.3 In the event of any of these signs or symptoms in 
patients with severe pulmonary hypertension, physicians should 
suspect the possibility of left main coronary artery obstruction. 
The definitive diagnosis of compression is attained by angiogra-
phy, whether or not associated with the intravascular ultrasound.3 
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Figure 2. Three-dimensional reconstruction of the pulmonary artery at the computed 
tomography angiography. The dilated pulmonary artery causes downward displace-
ment of the aortic root. Ao: aorta; PA: main pulmonary artery.
Figure 3. Intravascular ultrasound performed after stent implantation in the left main coronary artery (LMCA) showing image suggestive of stent strut malapposition (A). Coro-
nary angiography (right anterior oblique caudal projection) after the 4.0 x 28 mm drug-eluting stent implantation in the LMCA, followed by post-dilation with a 4.5 x 15 mm 
non-compliant balloon catheter (B). LAD: left anterior descending artery; CX: circumflex artery.
The most appropriate projection is the left anterior oblique cranial 
view. Coronary computed tomography angiography has some ad-
vantages: in addition to depicting the obstruction, it can assess the 
pulmonary artery, its association with the left main coronary artery, 
and left ventricular function. It has the disadvantage of exposing the 
patient to radiation and iodinated contrast. Cardiac magnetic reso-
nance imaging can evaluate the characteristics of the myocardial 
muscle, adding little to the diagnosis of extrinsic compression. Due 
to its non-invasive characteristic, coronary computed tomography 
angiography should be initially requested and used during follow-
-up after treatment. Imaging tests that assess myocardial ischemia 
have not been efficient in the evaluation of myocardial perfusion in 
these patients.3 A likely hypothesis is that extensive ischemia caused 
by the obstruction would lead to a balanced in myocardial perfusion 
in several left ventricular segments, which would cause difficulties 
when analyzing these images. 
The best treatment for the extrinsic obstruction of the left main 
coronary artery by pulmonary artery dilation is yet to be esta-
blished. The performance of randomized controlled trials is difficult 
due to the small number of cases.
Myocardial revascularization can be performed through conven-
tional surgery or percutaneous stent implantation. Several authors 
consider the latter the best option, for different reasons.3-6 First, the 
risk that is inherent to the conventional surgery in these cases is in-
creased due to the presence of severe pulmonary hypertension. Se-
cond, the obstruction physiopathology is not atherosclerotic, which 
may result in lower rates of stent restenosis and an easier-to-per-
form percutaneous procedure. According to the reported cases, this 
type of treatment has shown to be effective and safe during the in-
-hospital and follow-up periods.3,4,6
The choice between bare-metal stent and drug-eluting stents is 
also yet to be defined. Some authors prefer bare-metal stents due to 
the non-atherosclerotic characteristic of the lesion and the large left 
main coronary artery diameters, which would make restenosis unli-
kely.4,6 However, the high efficacy and safety of drug-eluting stents 
in the treatment of atherosclerotic lesions in the left main coronary 
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Figure 4. Coronary computed tomography angiography performed 8 months after the 
percutaneous procedure. The image shows the stent implanted in the left main coro-
nary artery with no signs of extrinsic compression by the main pulmonary artery (PA). 
Ao: aorta; LA: left atrium.
artery make these the most often used devices in the reported ca-
ses.3 It has not been established whether routine angiographic con-
trol during follow-up of cases is necessary. As described above, 
coronary computed tomography angiography would probably be 
sufficient to rule out restenosis or late complications, considering 
the recent advances in the method. Nevertheless, in view of the mor-
bidity and large area of myocardium at risk, the use of dual antipla-
telet therapy for at least 1 year is recommended.
The treatment of pulmonary hypertension should be performed 
according to the etiology. Clinical control with vasodilators associa-
ted with percutaneous treatment of the lesion has also been descri-
bed.3 In schistosomiasis cases, treatment should involve specific 
measures for the parasitic infection. The pharmacological measures 
include antiparasitic treatment (praziquantel and artemether), even 
in newly diagnosed chronic forms. The treatment eliminates the 
adult parasites, which produces eggs, minimizing harm to the lung 
parenchyma. However, vascular remodeling establishes an irreversi-
bility point, in which the antiparasitic treatment alone is ineffective 
in preventing progressive worsening. The definitive treatment is he-
art-lung transplantation.7 
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